Cyclosporine: Structure, Pharmacokinetics, and Therapeutic Drug Monitoring

References

• White D. J. G. Cyclosporin A. Elsevier, Amsterdan 1982
   Google Scholar
• Kahan B. D. Cyclosporine: Biological Activity and Clinical Applications. Grune & Stratton, Orlando 1984
   Google Scholar
• Borel J. F. Cyclosporin. Prog. Allergy 1986; 38
   Google Scholar
• Borel J. F., Feuer C., Bubler H. U., Stahelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976; 6: 432
   Google Scholar
• Calne R. Y., White D. J. G., Thiru S., Evans D. B., McMaster P., Craddock G. N., Pentlow D. B., Rolles K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; 2: 1323
   PubMed Web of Science ®Google Scholar
• Stahelin H. Historical background. Prog. Allergy 1986; 38: 19
   Google Scholar
• Nickell S. P., Scheibel L. W., Cole G. A. Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Infect. Immun. 1982; 37: 1093
   PubMedGoogle Scholar
• Solback W., Forberg K., Kammerer E., Bogdan C., Rhollinghoff M. Suppressive effects of cyclosporine A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J. Immunol. 1986; 173: 702
   Google Scholar
• von Ruegger A., Kuhn M., Lichtl H., Loosil H.-R., Huguenin R., Quiquerez C., von Wartburg A. Cyclosporin, A., ein immunsuppressiv wirksamer Pepitidmetabolit aus Trichoderma polysporum (Link ex Pers.). Rifai, Helv. Chim. Acta 1976; 59: 1075
   Google Scholar
• Yee G. C., Gmur D. J., Kennedy M. S. Liquid-chromatographic determination of cyclosporine in serum with use of a rapid extraction procedure. Clin. Chem. 1982; 26: 2271
   Google Scholar
• Loosli H.-R., Kessler H., Oschkinat H., Webber H.-P., Petcher T. J., Widmer A. The conformation of cyclosporin A in the crystal and ion solution. Helv. Chim. Acta 1985; 68: 682
   Web of Science ®Google Scholar
• Kessler H., Loosli H.-R., Oschkinat H. Assignment of the 1H-, 13C-, and 15N-NMR spectra of cyclosporine A in CDC13 and C6D6 by a combination of homo- and heteronuclear two-dimensional techniques. Helv. Chim. Acta 1985; 68: 661
   Web of Science ®Google Scholar
• Bowers L. D., Mathews S. E. Investigation of the mechanism of peak broadening observed in the high-performance liquid chromatographic analysis of cyclosporine. J. Chromatogr. 1985; 333: 231
   PubMedGoogle Scholar
• Bowers L. D., Vine W., unpublished observations
   Google Scholar
• Paller M. S., Ferris T. F. Effects of Nva²-cyclosporine on glomerular filtration rate and renal blood flow in the rat, submitted
   Google Scholar
• Wenger R. M. Synthesis of ciclosporin and analogues: structural and conformational requirements for immunosuppressive activity. Prog. Allergy 1986; 38: 46
   PubMedGoogle Scholar
• Hiestand P. C., Gunn H. C., Gale J. M., Ryffel B., Borel J. F. Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2), dihydro-cyclosporine. Immunology 1985; 55: 249
   PubMed Web of Science ®Google Scholar
• Rosano T. G., Freed B. M., Cerilli J., Lempert N. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Transplantation 1986; 42: 262
   Google Scholar
• Hartman N. R., Trimble L. A., Vederas J. C., Jardine I. An acid metabolite of cyclosporine. Biochem. Biophys. Res. Commun. 1985; 133: 964
   PubMedGoogle Scholar
• Rich D. H., Khaon M. K., Dunlap B., Miller S. P. F. Synthesis and antimitogenic activities of four analogues of cyclosporin A modified in the 1-position. J. Med. Chem. 1986; 29: 978
   Google Scholar
• von Wartburg A., Traber R. Chemistry of the natural cyclosporin metabolites. Prog. Allergy 1986; 38: 28
   PubMedGoogle Scholar
• Klaus G. G. B., Chisholm P. M. Does cyclosporine act in vivo as it does in vitro?. Immunol. Today 1986; 7: 101
   Google Scholar
• Jeffery J. R., Cheung K., Masniuk J., Taylor D. Mixed lymphocyte culture responses. Transplantation 1984; 38: 42
   Google Scholar
• Suthanthiran M., Garovoy M. R. Immunologic monitoring of the renal transplant recipient. Urol. Clin. N. Am. 1983; 10: 315
   PubMedGoogle Scholar
• Wenger R. M., Payne T. G., Schreier M. H. Cyclosporine: chemistry, structure-activity relationships and mode of action. Prog. Clin. Biochem. Med. 1986; 3: 157
   Google Scholar
• von Wartburg A., Traber R. Chemistry of the natural cyclosporin metabolites. Prog. Allergy 1986; 38: 18
   Google Scholar
• von Traber R., Kuhn M., Ruegger A., Lichtl H., Loosli H.-R., von Wartburg A. Die struktur von cyclosporin C. Helv. Chim. Acta 1977; 60: 1247
   Google Scholar
• Maurer G. Metabolism of cyclosporine. Transplant. Proc 1985; 17: 19
   PubMed Web of Science ®Google Scholar
• Maurer G. Discussion. I. Transplant. Proc. 1985; 17: 34
   Google Scholar
• Donatsch P., Abisch E., Homberger M., Traber R., Trapp M., Voges R. A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J. Immunoassay. 1981; 2: 19
   PubMedGoogle Scholar
• Abisch E. Radioimmunoassay KIT 031180 instructions. Sandoz May, 1981
   Google Scholar
• Ciclosporin RIA-Kit instructions. Sandoz October, 1984
   Google Scholar
• Varghese Z., Cahn M. K., Steele L. V., Sweny P., Fernando O. N., Moorhead J. F. How to measure cyclosporine. Lancet 1984; 1: 1407
   Google Scholar
• Holt D. W., Marsden J. T., Johnston A. Measurement of cyclosporine: methodological problems. Transplant. Proc 1986; 18(S5)101
   Google Scholar
• Quesniaux V., Tees R., Schreier M. H., Wenger R. M., Donatsch P., Van Regenmortel M. H. V. Monoclonal antibodies to ciclosporin. Prog. Allergy 1986; 38: 108
   Google Scholar
• Mahoney W. C., Orf J. W. Derivatives of cyclosporine compatible with antibody-based assays: generation of 125I-labelled cyclosporine. Clin. Chem. 1985; 31: 459
   Google Scholar
• Wong P. Y., Cheung M., Yip T. K., Mee A. V. Use of 125I-labeIled-histamine-cycIosporine concentrations in transplantation patients. Clin. Chem. 1986; 32: 492
   Google Scholar
• Wang P., Morrison M. A., Wang N. A fluoresence polarization immunoassay (FPIA) for the quantitation of cyclosporine. Clin. Chem. 1986; 32: 1061
   Google Scholar
• Johnston A., Marsden J. T., Holt D. W. The United Kingdom cyclosporin quality assessment scheme. Ther. Drug Monit. 1986; 8: 200
   PubMedGoogle Scholar
• Gfeller J. C., Beck A. K., Seebach D. Erhohung der nachweisempfindlichkeit von cyclosporin A durch derivatsierung mit 2-naphthylselenylchlorid. Helv. Chim. Acta 1980; 63: 728
   Google Scholar
• Niederberger W., Schaub P., Beveridge T. High performance liquid chromatographic determination of cyclosporine A in plasma and urine. J. Chromatogr. 1980; 182: 454
   PubMedGoogle Scholar
• Lawrence R., Allwood M. C. Development of an analytical method to measure cyclosporine A concentrations in body fluids using HPLC. J. Pharm. Pharmacol. 1980; 32
   Google Scholar
• Sawchuck R. J., Cartier L. L. Liquid-chromatographic determination of cyclosporin A in blood and plasma. Clin. Chem. 1981; 27: 1368
   PubMedGoogle Scholar
• Nussbaumer K., Niederberger W., Keller H. P. Determination of cyclosporin A in blood and plasma by column switching-HPLC after rapid sample preparation. J. High Res. Chrom. Chrom. Commun. 1982; 5: 424
   Google Scholar
• Leyland-Jones B., Clark A., Kreis W., Dismore R., O'Reilly R., Young C. W. High performance liquid chromatographic determination of cyclosporin A in human plasma. Res. Commun. Chem. Pathol. Pharmacol. 1982; 37: 431
   PubMedGoogle Scholar
• Carruthers S. G., Freeman S. J., Koegler J. C., Howson W., Keown P. A., Laupacis A., Stiller C. R. Simplified liquid-chromatographic analysis for cyclosporin A., and comparison with radioimmunoassay. Clin. Chem. 1983; 29: 180
   PubMed Web of Science ®Google Scholar
• Smith H., Robinson W. Semi-automated high performance liquid chromatographic method for the determination of cyclosporine in plasma and blood using column switching. J. Chromatogr. 1984; 305: 353
   PubMedGoogle Scholar
• Kates R. E., Latini R. Simple and rapid high performance liquid chromatographic analysis of cyclosporine in human blood and serum. J. Chromatogr. 1984; 309: 441
   PubMedGoogle Scholar
• Lensmeyer G., Fields B. L. Improved liquid chromatographic determination of cyclosporine with concomitant determination of a cell-bound metabolite. Clin. Chem. 1985; 31: 196
   PubMedGoogle Scholar
• Hoffman N. E., Rustum A. M., Quebbeman E. J., Hamid A. A. R., Ausman R. K. HPLC determination of cyclosporine in whole blood. J. Liq. Chromatogr. 1985; 8: 2511
   Web of Science ®Google Scholar
• Garraffo R., Lapalus P. Simplified liquid chromatographic analysis of cyclosporin A in blood and plasma with the use of rapid extraction. J Chromatogr. 1985; 337: 416
   PubMedGoogle Scholar
• Gmur D. J., Yee G. C., Kennedy M. S. Modified column-switching high-performance liquid chromatographic method for the measurement of cyclosporine in serum. J. Chromatogr. 1985; 344: 422
   PubMedGoogle Scholar
• Shihabi A. K., Scaro J., David R. M. A rapid method for cyclosporine. A determination by HPLC. J. Liq. Chromatogr. 1985; 8: 2641
   Web of Science ®Google Scholar
• Moyer T. P., Johnson P., Faynor S. M., Sterioff S. Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate chromatographic procedure that solves these problems. Clin. Biochem. 1986; 19: 83
   Google Scholar
• Kabra P., Wall J., Blanckaert N. Solid phase extraction and liquid chromatography for improved assay of cyclosporine in whole blood and plasma. Clin. Chem. 1986; 31: 1717
   Google Scholar
• Kahn G. C., Shaw L. M., Kane M. D. Routine monitoring of cyclosporine in whole blood and kidney tissue using high performance liquid chromatography. J. Anal. Toxicol 1986; 10: 28
   Google Scholar
• Bowers L. D., Singh J. A gradient elution HPLC assay for cyclosporine and its metabolites in blood and bile. J. Liq. Chromatogr.
   Google Scholar
• Annesley T., Matz K., Balogh L., Clayton L., Glacerio D. Liquid chromatographic analysis of cyclosporine utilizing a microbore column and reduced specimen requirement. Clin. Chem. 1986; 32: 1407
   PubMed Web of Science ®Google Scholar
• Vine W., Flye M. W., Jatlow P. Cyclosporine concentrations: serum, whole blood and bile relationships following renal and hepatic transplantation. Clin. Chem. 1986; 32: 1828
   Google Scholar
• Dimson P. Varian Instruments, persona’ communication
   Google Scholar
• Kohler J., Chase D. B., Farlee R. D., Vega A. J., Kirkland J. J. Comprehensive characterization of some silica-based stationary phases for high-performance liquid chromatography. J. Chromatogr. 1986; 352: 275
   Web of Science ®Google Scholar
• Oosterhuizen M. M. J., Jacobs D. R., Myburgh J. A. Preparation, extraction, and high-performance liquid chromatography of cyclosporin A from plasma that contains interferring compounds. Ann. Clin. Biochem. 1985; 22: 402
   Google Scholar
• Rocher L. L., Giacherio D., Annesley T. Refinement in HPLC analysis for cyclosporine: comparison of two alkyl chain columns. Transplant. Proc 1986; 18: 652
   Google Scholar
• Freeman D. J., Laupaeis A., Keown P. A., Stiller C. R., Carruthers S. G. Evaluation of cyclosporine-phenytoin interactions with observations on cyclosporine metabolites. Br. J. Clin. Pharmacol. 1984; 18: 886
   Google Scholar
• Bowers L. D., Canafax D. M., Singh J., Seifedlin R., Simmons R. L., Najarian J. S. Studies of cyclosporine blood levels: analysis, clinical utility, pharmacokinetics, metabolites, and chronopharmacology. Transplant. Proc 1986; 18(S5)137
   Google Scholar
• Rosano T. G., Freed B. M., Pell M. A., Lempert N. Cyclosporine metabolites in human blood and renal tissue. Transplant. Proc 1986; 18(S5)35
   Google Scholar
• Robinson C. A., Ketchum C. H. Monitoring of cyclosporin A: is it possible?. Ther. Drug Monit. 1983; 5: 371
   Google Scholar
• Robinson W. T., Schran H. F., Barry E. P. Methods to measure cyclosporine levels — high performance liquid chromatography, radioimmunoassay, and correlation. Transplant. Proc 1983; 15: 2403
   Google Scholar
• Abisch E., Beveridge T., Gratwohl A., Neiderberger W., Nussbaumer K., Schaub P., Speck B., Trapp M. Cyclosporin A: correlation between HPLC and RIA serum levels. Pharm. Weekbl. (Sci. Ed.) 1982; 4: 84
   PubMedGoogle Scholar
• Kahan B. D. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation 1985; 40: 457
   PubMed Web of Science ®Google Scholar
• Kahan B. D., Reid M., Newburger J. Pharmacokinetics of cyclosporine in human renal transplantation. Transplant. Proc 1983; 15: 446
   Google Scholar
• Keown P. A., Stiller C. R., Laupaeis A. L., Howson W., Coles R., Stawecki M., Koegler A., Carruthers G., McKensie N., Sinclair N. R. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Transplant. Proc 1982; 14: 659
   Google Scholar
• Keown P. A., Stiller C. R., Sinclair N. R., Carruthers G., Howson W., Stawecki M., McMichael M., Koegler A., McKensie N., Wall W. The clinical relevance of cyclosporine blood levels as measured by radioimmunoassay. Transplant. Proc 1983; 15: 2438
   Web of Science ®Google Scholar
• Lemaire M., Maurer G., Wood A. J. Pharmacokinetics and metabolism. Prog. Allergy 1986; 38: 93
   Google Scholar
• Ptachcinski R. J., Venkataramanan R., Rosenthal J. T., Burckart G. J., Taylor R. J., Hakala T. R. The effect of food on cyclosporine absorption. Transplantation 1985; 40: 174
   PubMed Web of Science ®Google Scholar
• Venkataramanan R., Perez H. D., Schwinghammer T., Burckart G. J., Ptachinski R. J., Van Thiel D. J., Starzl T. E. Effect of bile on cyclosporine absorption in dogs. Res. Commun. Chem. Pathol. Pharmacol. 1986; 53: 137
   Google Scholar
• Venkataramanan R., personal communication
   Google Scholar
• Lemaire M., Tillemont J. P. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J. Pharm. Pharmacol. 1982; 34: 715
   PubMed Web of Science ®Google Scholar
• Wenk M., Follath F., Abisch E. Temperature dependency of apparent cyclosporin A concentrations in plasma. Clin. Chem. 1983; 29: 1865
   PubMedGoogle Scholar
• Niederberger W., Lemaire M., Maurer G., Nussbaumer K., Wagner O. Distribution of cyclosporin in blood components and tissues. Transplant. Proc 1983; 15: 2419
   Web of Science ®Google Scholar
• Dieperink H. Temperature dependency of cyclosporin plasma levels. Lancet 1983; 1: 416
   Google Scholar
• Agarwal R. P., McPherson R. A., Threatte G. A. Assessment of cyclosporin A in whole blood and plasma in five patients with different hematocrits. Ther. Drug Monit. 1985; 7: 61
   Google Scholar
• Annesley T. M., Giacherio D. A., Feldkamp C. S. The concentration-related distribution of cyclosporine. J. Clin. Immunoassay 1986; 9: 53
   Google Scholar
• Yatscoff R. W., Rush D. N., Jeffery J. R. Effects of sample preparation on concentrations of cyclosporin A measured in plasma. Clin. Chem. 1984; 30: 1812
   Google Scholar
• Rosano T. G. Effect of hematocrit on cyclosporine in whole blood and plasma of renal-transplant patients. Clin. Chem. 1985; 21: 410
   Google Scholar
• Mras W., Zink R. A., Graf A., Preis D., Illner W. D., Land W., Siebert W., Zottlein H. Distribution and transfer of cyclosporine among the various human lipoprotein classes. Transplant. Proc 1983; 15(S1)2426
   Google Scholar
• Gurecki J., Warty V., Sanghvi A. The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients. Transplant. Proc 1985; 17: 1997
   Google Scholar
• Sgoutas D., Macmahon W., Love A., Jerkunica I. Interaction of cyclosporin A with human lipoproteins. J. Pharm. Pharmacol. 1986; 38: 583
   PubMedGoogle Scholar
• Lithell H., Odlind B., Selinus I., Lindberg A., Lindstrom B., Frodin L. Is the plasma lipoprotein pattern of importance for treatment with cyclosporine?. Transplant. Proc 1986; 18: 50
   Google Scholar
• Maurer G., Lemaire M. Biotransformation and distribution in blood of cyclosporine and its metabolites. Transplant Proc. 1986; 18(S5)25
   Google Scholar
• Bennett M. J., Carpenter K. H., Worthy E., Lilleyman J. S. Cyclosporine concentrations in whole blood and plasma. Clin Chem. 1984; 30: 817
   Google Scholar
• Jatlow P. Yale University, personal communication
   Google Scholar
• Venkataramanan R., Ptachcinski R. J., Burckart G. J., Yang S. L., Starzl T. E. The clearance of cyclosporine by hemodialysis. J Clin. Pharmacol. 1984; 24: 528
   Google Scholar
• Flechner S. M., Katz A. R., Rogers A. J., Van Buren C., Kahan B. D. The presence of cyclosporine in body tissue and fluids during pregnancy. Am. J. Kidney Dis. 1985; 5: 60
   PubMed Web of Science ®Google Scholar
• Beveridge T., Gratwohl A., Michot F., Neiderberger W., Neusch E., Nussbaumer K., Schaub P., Speck B. Cyclosporin A: pharmacokinetics after a single dose in man and serum levels after multiple dosing in recipients of allogeneic bone-marrow grafts. Curr. Ther. Res. 1981; 30: 5
   Web of Science ®Google Scholar
• Beveridge T. Pharmacokinetics and metabolism of cyclosporin A. Cyclosporin A, D. J. G. White. Elsevier, Amsterdan 1982; 35
   Google Scholar
• Foliath F., Wenk M., Vozeh S., Thiel G., Brunner F., Loertscher R., Lemaire M., Nussbaumer K., Neiderberger W., Wood A. Intravenous cyclosporine kinetics in renal failure. Clin. Pharmacol. Ther. 1983; 34: 638
   Google Scholar
• Ptachcinski R. J., Venkataramanan R., Rosenthal J. T., Burckart G. J., Taylor R. J., Hakala T. R. Cyclosporine kinetics in renal transplantation. Clin. Pharmacol. Ther. 1985; 38: 296
   PubMed Web of Science ®Google Scholar
• Henny F. C., Kleinbloesem C. H., Moolenaar A. J., Paul L. C., Breimer D. D., Van Es L. A. Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients. Transplantation 1985; 40: 261
   Google Scholar
• Kahan B. D., Kramer W. G., Wideman C., Flechner S. M., Lo M. L., Van Buren C. T. Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay. Transplantation. 1986; 41: 459
   PubMed Web of Science ®Google Scholar
• Yee G. C., Kennedy M. S., Storb R., Thomas E. D. Pharmacokinetics of intravenous cyclosporine in bone marrow transplant recipients. Transplantation 1984; 38: 511
   PubMedGoogle Scholar
• Stewart C. F., Cochran E., Williams J. Cyclosporine disposition in patients with liver disease. Drug Intell. Clin. Pharm. 1985; 19: 451
   Google Scholar
• Robson S., Neuberger J., Keller H. P., Abisch E., Niederberger W., Von Graffenreid B., Williams R. Pharmacokinetic study of cyclosporin A (Sandimmun) in patients with primary biliary cirrhosis. Br. J. Clin. Pharmacol. 1984; 18: 627
   Google Scholar
• Venkataramanan R., Burckart G. J., Ptachcinski R. J., Lee A., Hardesty R. E., Griffith B. T. Cyclosporine pharmacokinetics in heart transplant patients. Transplant. Proc 1986; 18: 768
   Google Scholar
• Fidelius-Gort R. K., Ferguson R. M. The immunosuppressive action of cyclosporine in man. Transplant. Proc 1983; 15: 2350
   Google Scholar
• Rogers A. J., Yoshimura N., Kerman R. H., Kahan B. D. Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipients. Transplantation 1984; 38: 657
   Google Scholar
• Bowers L. D., Rabatin J. T., Wick M., Canafax D. M., Hrushesky W. J. M., Benson E. S. Circadian pharmacodynamics of cyclosporine in rats and man. Annu. Rev. Chronopharmacol.
   Google Scholar
• Venkataramanan R., Yang S. L., Burckart G. J., Ptachcinski R. J., Van Theil D. H., Starzl T. E. Diurnal variations in cyclosporine kinetics. Ther. Drug Monit. 1986; 8: 380
   PubMed Web of Science ®Google Scholar
• Maurer G., Loosli H. R., Schreier E., Keller B. Disposition of cyclosporine in several animal species and man. Drug Metab. Dispos. 1984; 12: 120
   PubMed Web of Science ®Google Scholar
• Hartman N. R., Trimble L. A., Vederas J. C., Jardine I. An acid metabolite of cyclosporine. Biochem. Biophys. Res. Commun. 1985; 133: 964
   PubMedGoogle Scholar
• Hartman N. R., Jardine I. Mass spectrometnc analysis of cyclosporine metabolites. Biomed. Environ. Mass Spectrosc 1986; 13: 361
   Google Scholar
• Singh J., Sukalski K., Bowers L. D. Investigation of cyclosporine metabolism in the isolated perfused rat liver, in preparation
   Google Scholar
• Schroeder T. J., Wadhwa N. K., Pesce A. J., First M. R. An acute overdose of cyclosporine. Transplantation 1986; 41: 406
   Google Scholar
• Venkataramanan R., Starzl T. E., Yang S., Burckart G. J., Ptachcinski R. J., Shaw B. W., Iwatsuki S., Van Thiel D. H., Sanghi A., Seltman H. Biliary excretion of cyclosporine in liver transplant patients. Transplant. Proc 1985; 17: 286
   PubMed Web of Science ®Google Scholar
• Burckart G. J., Starzl T. E., Venkataramanan R., Hashem H., Wong L., Wang C., Makowka L., Zeevi A., Ptachcinski R. J., Knapp J. E., Iwatsuki S., Esquivel C., Sanghi A., Van Thiel D. J. Excretion of cyclosporine and its metabolites in human bile. Transplant. Proc 1986; 18(S5)46
   Google Scholar
• Burckart G. J., Venkataramanan R., Starzl T. E., Ptachcinski R. J., Gartner J. C., Rosenthal T. Cyclosporine clearance in children following organ transplantation. J. Clin. Pharmacol. 1984; 24: 412
   Google Scholar
• Ferguson R. M., Sutherland D. E. R., Simmons R. L., Najarian J. S. Ketoconazole, cyclosporine metabolism, and renal transplantation. Lancet. 1982; 2: 832
   Google Scholar
• Morgenstern G. R., Powles R., Robinson R., McElwain T. J. Cyclosporine interaction with ketoconazole and melphalan. Lancet 1982; 2: 1342
   Google Scholar
• Ptachcinski R. J., Carpenter B. J., Burckart G. J., Venkataramanan R., Rosenthal J. T. Effect of erythromycin on cyclosporine levels. N. Engl. J. Med. 1985; 313: 1416
   PubMed Web of Science ®Google Scholar
• Hourmant M., LeBigot J. F., Vernillet L., Sangniez G., Remi J. P., Soulillou J. P. Coadministration of erythromycin results in an increase of blood cyclosporine to toxic levels. Transplant. Proc. 1986; 17: 2723
   Google Scholar
• Freeman D. J., Martell R., Carruthers S. G., Keown P. A. The effect of erythromycin on the pharmacokinetics of cyclosporine. Clin. Pharmacol. Ther. 1986; 39: 193
   Google Scholar
• Wallwork J., McGregor O. G. A., Wells F. C., Cory-Pearch R., English T. A. H. Cyclosporine and intravenous sulphadimidise and trimethoprin therapy. Lancet 1983; 1: 366
   PubMed Web of Science ®Google Scholar
• Klintmalm G., Sawe J. Prednisolone increases cyclosporine levels in renal transplant patients. Lancet 1984; 1: 731
   PubMedGoogle Scholar
• Ptachcinski R. J., Venkataramanan R., Burckart G. J., Hakala T. R., Rosenthal J. T., Carpenter B. J., Taylor R. J. Cyclosporine — high dose steroid interaction in renal transplant patients: assessment by HPLC. Transplant. Proc 1987; 19: 1728
   Google Scholar
• Allen R. D., Hunnisett A. G., Morris R. J. Cyclosporine and rifampsin in renal transplantation. Lancet 1985; 2: 980
   Google Scholar
• Van Buren D., Wideman C. A., Reid M., Gibbons S., Van Buren C. T. The antagonistic effect of rifampsin upon cyclosporine bioavailability. Transplant. Proc 1984; 16: 1642
   Web of Science ®Google Scholar
• Langhoff E., Madsen S., Flachs H., Olgaard K., Ladefoged J., Hvidberg E. F. Inhibition of prednisone metabolism by cyclosporine in kidney-transplanted patients. Transplantation 1985; 39: 107
   PubMedGoogle Scholar
• Augustine J. A., Zemaitas M. A. The effects of cyclosporine A (CsA) on hepatic microsomal drug metabolism in the rat. Drug Metab. Disp. 1986; P14: 73
   Google Scholar
• Whiting P. H., Simpson J. G., Thomson A. W. Nephrotoxicity of cyclosporine in combination with aminoglycoside and cephalosporin antibiotics. Transplant. Proc 1983; 15: 2702
   Google Scholar
• Whiting P. H., Burke M. D., Thomson A. W. Drug interactions with cyclosporine: implications from animal studies. Transplant. Proc 1986; 18(S5)56
   Google Scholar
• Kennedy M. S., Deeg H. J., Siegl M., Crowley J. J., Storb R., Thomas E. D. Acute renal toxicity with combined use of amphtericin B and cyclosporine after bone marrow transplantation. Transplantation 1983; 35: 211
   PubMed Web of Science ®Google Scholar
• Thompson J. F., Chalmers D. H. K., Hunnisett A. G. W., Wood R. F. M., Morris R. J. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine. Transplantation 1983; 36: 204
   Google Scholar
• Kloke O., Osieka R. Interaction of cyclosporin A with antineoplastic agents. Klin. Wochenschr. 1985; 63: 1081
   Google Scholar
• Poochet J. M., Pirson Y. Cyclosporine-diltiazem interaction. Lancet 1986; 1: 979
   Google Scholar
• Ross E. B., Roberts D., Griffiths P. J. A., Salaman J. R. Cyclosporine interaction with danazol and norethisterone. Lancet 1986; 1: 330
   Google Scholar
• Freeman D. J., Laupacis A., Keown P. A. Annu. Rev. Coll. Phys. Surg. Can. 1984; 17: 301
   Google Scholar
• Bourbigot B., Guiserix J., Airiau J., Bressolette L., Morin J. F., Cledes J. Nicardipine increases cyclosporine blood levels. Lancet 1986; 1: 1447
   Google Scholar
• Jarowenko M. V., Van Buren C. T., Kramer W. G., Lorber M. I., Flechner S. M., Kahan B. D. Rantidine, cimetidine, and the cyclosoprine-treated recipient. Transplantation 1986; 42: 311
   Google Scholar
• Nussenblatt R. B., Austin H. A., Palestine A. G., Preuss H. G. Hydergine and cyclosporine, toxicity. Lancet 1986; 1: 1220
   Google Scholar
• Vine W., unpublished observation
   Google Scholar
• Kronke M., Leonard W. J., Depper J. M., Arya S. K., Wong-Staal F., Gallo R. C., Waldmann T. A., Greene W. C. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 5214
   PubMed Web of Science ®Google Scholar
• Dupont E., Huygen K., Schandene L., Vandercruys M., Palfliet K., Wybran J. Influence of in vivo immunosuppressive drugs on production of lymphokines. Transplantation 1985; 39: 143
   PubMedGoogle Scholar
• Reem G. H., Cook L. A., Vilcek J. Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science 1983; 221: 63
   PubMed Web of Science ®Google Scholar
• Hess A. D. Effect of interleukin 2 on the immunosuppressive action of cyclosporine. Transplantation 1985; 39: 62
   PubMed Web of Science ®Google Scholar
• Buurman W. A., Ruers T. J. M., Daemen I. A. J. M., van der Linden C. J., Groenewegen G. Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells. Transplantation 1986; 136: 4035
   Google Scholar
• Heidecke C. D., Nicolaus C., Stadler J., Florack G., Holscher M. Measurement of cyclosporin bioactivity in serum of renal transplant recipients: development and comparison with RIA. Transplant. Proc 1987; 19: 1734
   Google Scholar
• Kunkl A., Klaus G. G. B. Selective effects of cyclosporin A on functional B cell subsets in the mouse. J. Immunol. 1980; 125: 2526
   PubMed Web of Science ®Google Scholar
• Hess A. D., Colombani P. M., Esa A. H. Cyclosporine and the immune response: basic aspects. Crit. Rev. Immunol. 1986; 6: 123
   Google Scholar
• Shevach E. M. The effects of cyclosporin A on the immune system. Annu. Rev. Immunol. 1985; 3: 397
   PubMed Web of Science ®Google Scholar
• Thomson A. W. Immunobiology of cyclosporin A — a review. J. Exp. Biol. Med. Sci. 1983; 61: 147
   PubMedGoogle Scholar
• Starzl T. E., Iwatsuki D. C. S., Shaw B. W., Jr., Gordon R. D., Esquivel C. Liver transplantation in the cyclosporin era. Prog. Allergy. 1986; 38: 366
   Google Scholar
• Busuttil R. W., Goldstein L. I., Danovitch G. M., Amient M. E., Memsic L. D. F. Liver transplantation today, Ann. Intern. Med. 1986; 104: 377
   Google Scholar
• McGregor C. G. A., Oyer P. E., Shumway N. E. Heart and heart-lung transplantation. Prog. Allergy 1986; 38: 346
   PubMedGoogle Scholar
• Starnes V. A., Jamieson S. W. Current status of heart and lung transplantation. World J. Surg. 1986; 10: 442
   Google Scholar
• Sutherland D. E. R., Fryd D. S., Strand M. H., Canafax D. M., Ascher N. L., Payne W. D., Simmons R. L., Najarian J. S. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Am. J. Kidney Dis. 1985; 5: 318
   PubMed Web of Science ®Google Scholar
• Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N. Engl. J. Med. 1986; 314: 1219
   PubMed Web of Science ®Google Scholar
• Merion R. M., White D. J. G., Thiru S., Evans D. B., Calne R. Y. Cyclosporine: five years' experience in cadaveric renal transplantation. N. Engl. J. Med. 1984; 310: 148
   PubMed Web of Science ®Google Scholar
• Calne R. Y. Pancreas transplantation. Prog. Allergy 1986; 38: 395
   Google Scholar
• Gratwohl A., Speck B. Bone marrow transplantation with ciclosporin. Prog. Allergy 1986; 38: 404
   PubMedGoogle Scholar
• Storb R., Deeg H. J., Whitehead J., Appelbaum F., Beatty P., Bensinger W., Buckner C. D., Clift R., Doney K., Farewell V., Óansen J., Hill R., Lum L., Martin P., McGuffin R., Sanders J., Stewart P., Sullivan K., Witherspoon R., Yee G., Thomas E. D. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N. Engl. J. Med. 1986; 314: 729
   PubMed Web of Science ®Google Scholar
• Schmitz-Schumann M. Interim report of clinical studies presented at the International Symposium on Ciclosporin in Auto-Immune Disease. Prog. Allergy 1986; 38: 436
   Google Scholar
• Palestine A. G., Austin H. A., Balow J. E., Antonovych T. T., Sabnis S. G., Preuss H. G., Nussenblatt R. B. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N. Engl. J. Med., 314: 1293
   Google Scholar
• Berg K. J., Forre O., Bjerkhoel F., Amundsen E., Djoseland O., Rugstad H. E., Westre B. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int. 1986; 29: 1180
   PubMed Web of Science ®Google Scholar
• von Graffenried B., Harrison W. B. Renal function in patients with autoimmune diseases treated with cyclosporine. Transplant. Proc 1985; 17: 215
   PubMedGoogle Scholar
• Stiller C. R., Dupre J., Gent M., Jenner M. R., Keown P. A., Laupacis A., Martell R., Rodger N. W., Von Graffenried B., Wolfe B. M. J. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1986; 223: 1362
   Google Scholar
• Feutren G., Assan Karsenty R. G., Du Rostu H., Sirmai J., Papoz L., Vialettes B., Vexiau P., Rodier M., Lallemand A., Bach J.-F. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Lancet 1986; 2: 120
   Google Scholar
• Cohen D. J., Loertscher R., Rubin M. F., Tilney N. L., Carpenter C. B., Strom T. B. Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann. Intern. Med. 1984; 101: 667
   PubMed Web of Science ®Google Scholar
• Bennett W. M., Norman D. J. Action and toxicity of cyclosporine. Annu. Rev. Med. 1986; 37: 215
   PubMed Web of Science ®Google Scholar
• Thiel G. Nephrotoxicity of ciclosporin. Tips 1986; 167
   Google Scholar
• Bennet W. M., Pulliam J. P. Cyclosporine nephrotoxicity. Ann. Intern. Med. 1983; 99: 851
   Google Scholar
• Flechner S. M., Payne W. D., Van Buren C., Kerman R., Kahan B. D. The effect of cyclosporine on early graft function in human renal transplantation. Transplantation 1983; 36: 268
   PubMed Web of Science ®Google Scholar
• Klintmalm G., Sundelin B., Bohman S.-O., Wilczek H. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period. Lancet 1984; 2: 950
   PubMed Web of Science ®Google Scholar
• Iwatsuki S., Starzl T. E., Shaw B. W., Jr., Áang S. L., Zitelli B. J., Gartner J. C., Malatack J. J. Long-term use of cyclosporine in liver recipients. Transplantation 1983; 36: 641
   Google Scholar
• Powell-Jackson P. R., Young B., Calne R. Y., Williams R. Nephrotoxicity of parenterally administered cyclosporine after orthotopic liver transplantation. Transplantation 1983; 36: 505
   Google Scholar
• Iwatsuki S., Esquivel C. O., Klintmalm G. B. G., Gordon R. D., Shaw B. W., Jr., Starzl T. E. Nephrotoxicity of cyclosporine in liver transplantation. Transplant. Proc 1985; 17: 191
   PubMedGoogle Scholar
• Myers B. D., Ross J., Newton L., Luetscher J., Perlroth M. Cyclosporine-associated chronic nephropathy. N. Engl. J. Med. 1984; 311: 699
   PubMed Web of Science ®Google Scholar
• Martin M., Packham D. K., Kingswood J. C., Cairns H., Khaghani A., Thompson F. D., Yacoul M. H. Determinants of cyclosporin nephrotoxicity following cardiac transplantation. Transplant. Proc 1987; 19: 2516
   Google Scholar
• Shulman H., Striker G., Deeg H. J., Kennedy M., Storb R., Thomas E. D. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N. Engl. J. Med. 1981; 305: 1392
   PubMed Web of Science ®Google Scholar
• Atkinson K., Biggs J. C., Hayes J., Ralston M., Dodds A. J., Concannon A. J., Naidoo D. Cyclosporin A associated nephrotoxicity in the first 100 days after allogenic bone marrow transplantation: three distinct syndromes. Br. J. Haematol. 1983; 54: 59
   PubMed Web of Science ®Google Scholar
• Hows J. M., Chipping P. M., Fairhead S., Smith J., Baughan A., Gordon-Smith E. C. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A. Br. J. Haematol. 1983; 54: 69
   PubMed Web of Science ®Google Scholar
• Kennedy M. S., Deeg H. J., Siegel M., Crowley J. J., Storb R., Thomas E. D. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation 1983; 35: 179
   Google Scholar
• Taube D., Neiled G., Hobby P., Holt D., Welsh K., Cameron J. S. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function. Transplant. Proc 1985; 17: 179
   Google Scholar
• Taube D. H., Williams D. G., Hartley B., Rudge C. J., Neild G. H., Cameron J. S., Ogg C. S., Welsh K. I. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients. Lancet 1985; 2: 172
   Google Scholar
• Solez K., McGraw D. J., Beschorner W. E., Kone B. C., Racusen L. C., Whelton A., Burdick J. F. Reflections on use of the renal biopsy as the “gold standard” in distinguishing transplant rejection from cyclosporine nephrotoxicity. Transplant. Proc 1985; 17: 123
   PubMedGoogle Scholar
• Verani R. R., Flechner S. M., Van Buren C. T., Kahan B. D. Acute cellular rejection or cyclosporine A nephrotoxicity? A review of transplant renal biopsies. Am. J. Kidney Dis. 1984; 4: 185
   PubMed Web of Science ®Google Scholar
• Sibley R. K., Rynasiewicz J., Ferguson R. M., Fryd D., Sutherland D. E. R., Simmons R. L., Najarian J. S. Morphology of cyclosporine nephrotoxity and acute rejection in patients immuno-suppressed with cyclosporine and prednisone. Surgery 1983; 94: 225
   PubMed Web of Science ®Google Scholar
• Keown P. A., Stiller C. R., Wallace A. C., McKenzie F. N., Wall W. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury. Transplant. Proc 1985; 17: 2247
   Google Scholar
• Rogerson M. E., Marsden J. T., Reid K. E., Bewick M., Holt D. W. Cyclosporine blood concentrations in the management of renal transplant recipients. Transplantation 1985; 41: 276
   Google Scholar
• Irschik E., Tilg H., Niederwieser D., Gastl G., Huber C., Margreiter R. Cyclosporine blood levels do correlate with clinical complications. Lancet 1984; 2: 692
   PubMed Web of Science ®Google Scholar
• Henny F. C., Kleinbloesem C. H., Moolenaar A. J., Paul L. C., Breimer D. D., van Es L. A. Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients. Transplantation 1985; 40: 261
   Google Scholar
• White D. J. G., McNaughton D., Calne R. Y. Is the monitoring of cyclosporin-A serum levels of clinical value?. Transplant. Proc 1983; 15: 454
   Google Scholar
• Williamson E. P. M., Millar R. J., Criddle R. A., Sells R. A. The differentiation of cyclosporin nephrotoxicity and acute rejection by urine cytology. Transplant. Proc 1987; 19: 1785
   Google Scholar
• Eggensperger D., Light J. A., O'Dowd G., Schweitzer S. The utility of cytodiagnostic urinalysis in the evaluation of renal allograft dysfunction: a clinicopathologic analysis of 122 urine specimens and 46 biopsies. Transplant. Proc 1987; 19: 1787
   Google Scholar
• Kahan B. D., Van Burne C. T., Flechner S. M., Jarowenko M., Yasumura T., Rogers A. J., Yoshimura N., LeGrue S., Drath D., Kerman R. H. Clinical and experimental studies with cyclosporine in renal transplantation. Surgery 1985; 97: 125
   Google Scholar
• Diethelm A. G. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity. Transplant. Proc 1986; 17: 82
   Google Scholar
• Canafax D. M., Torres A., Fryd D. S., Heil J. E., Strand M. H., Ashcer N. L., Payne W. D., Sutherland D. E. R., Simmons R. L., Najarian J. S. The effects of delayed function on recipients of cadaver renal allografts. Transplantation 1986; 41: 177
   PubMedGoogle Scholar
• Rolles K., Calne R. Y. Cyclosporine in the first month posttransplant. Transplant. Proc. 1986; 18: 55
   Google Scholar
• Hong J. H., Lipkowitz G. S., Yen C. Y., Greenstein S. M., Manis T., Butt K. M. H. Impact of immunosuppressive regimen on early posttransplant renal function. Transplant. Proc 1987; 19: 2106
   Google Scholar
• Tilney N. L., Milford E. L., Araujo J.-L., Strom T. B., Carpenter C. B., Kirkman R. L. Experience with cyclosporine and steroids in clinical renal transplantation. Ann. Surg. 1984; 200: 605
   PubMed Web of Science ®Google Scholar
• Chapman J. R., Morris P. J. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine. Transplant. Proc 1985; 17: 254
   Google Scholar
• Mendez R., Koussa N., Alanidzi A., Mendez R. G., Iwaki Y., Bogard T. P., Khetan U. Perioperative cyclosporine: interaction with multifactorial variables and effect on allograft function. Transplant. Proc 1986; 18: 12
   Google Scholar
• Simmons R. L., Canafax D. M., Fryd D. S., Ascher N. L., Payne W. D., Sutherland D. E. R., Najarian J. S. New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation. Transplant. Proc 1986; 17: 76
   Google Scholar
• Schareck W. D., Hopt U. T., Muller G. H., Greger G., Risler T., Bockhorn H. Improvement of initial renal function after kidney transplantation by combining CyA with azathioprine and steroids. Transplant. Proc 1987; 19: 1937
   Google Scholar
• Lewis R., Novick A., Hodge E., Streem S., Steinmuller D., Cunningham R., Steinhilber D. Effect of initial versus delayed cyclosporine therapy in cadaver renal transplantation. Transplant. Proc 1987; 19: 2088
   Google Scholar
• Ferguson R. M., Canafax D. M., Sawchuck R. T., Simmons R. L. Cyclosporine blood level monitoring: the early posttransplant period. Transplant. Proc 1986; 18: 113
   Google Scholar
• Matas A. J., Tellis V. A., Quinn T., Soberman R., Veith F. J. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant — an overview. Transplant. Proc 1986; 18: 141
   Google Scholar
• Steinmuller D. R. Usefulness of cyclosporine levels one to six months posttransplant. Transplant. Proc 1986; 18: 158
   Google Scholar
• Foley R. J., Hamner R. W., Weinman E. J. Serum potassium concentrations in cyclosporine- and azathioprine-treated renal transplant patients. Nephron 1985; 40: 280
   Google Scholar
• Adu D., Michael J., Turney J., McMaster P. Hyperkalemia in cyclosporin-treated renal allograft recipients. Lancet 1983; 2: 370
   Google Scholar
• Grino J. M., Sabater I., Castelao A. M., Torras J., Alsina J. Cyclosporine, uric acid, and the kidney. Lancet 1985; 1: 701
   Google Scholar
• June C. H., Thompson C. B., Kennedy M. S., Nims J., Thomas E. D. Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation 1985; 39: 620
   PubMed Web of Science ®Google Scholar
• Kahan B. D., Lorber M. I., Flechner S. M., Van Burne C. T., Jensen C., Wideman C. A. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases. Transplant. Proc 1986; 18: 59
   Google Scholar
• Simmons R. L., Canafax D. M., Strand M., Ascher N. L., Payne W. D., Sutherland D. E. R., Najarian J. S. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Transplant. Proc 1985; 18: 266
   Google Scholar
• Lorber M. I., Flechner S. M., Van Burne C. T., Kerman R. H., Kahan B. D. Cyclosporine, azathioprine, and prednisone as treatment of cyclosporine-induced nephrotoxicity in renal transplant recipients. Transplant. Proc 1985; 17: 282
   Google Scholar
• Post G. R., Moyer T. P., Anderson C. F., Sterioff S. Long-term cyclosporine for renal allograft patients does not cause nephrotoxicity. Transplant. Proc 1987; 19: 1761
   Google Scholar
• Norris C., Kupin W., Venkatachalam K., Green D., Oh H., Dienst S., Levin N. Low cyclosporine levels can maintain effective long term immunosuppression in primary cadaveric renal transplant recipients. Transplant. Proc
   Google Scholar
• Deierhoi M. H., Sollinger H. W., Kalayoglu M., Belzer F. O. Quadruple therapy for cadaver renal transplantation. Transplant. Proc 1987; 19: 1917
   Google Scholar
• Canafax D. M. Combination immunosuppression: azathioprine, cyclosporine and prednisone for recipients of HLA mismatched related donor and with ALG, AZA, CSA and P for recipients of cadaver donor renal allografts. Transplant. Proc 1985; 17: 2671
   Google Scholar
• Flechner S. M., Lorber M., Van Burne C., Kerman R., Kahan B. D. The case against conversion to azathioprine in cyclosporine-treated renal recipients. Transplant. Proc 1985; 17: 276
   Google Scholar
• Tegzess A. M., Van Son W. J., Beelen J. M., Meijer S., van der Woude F. J., Sloof M. J. H. Improvement in renal function followed by late onset graft rejection after conversion from cyclosporine to prednisone/azathioprine in renal transplant patients. Transplant. Proc 1987; 19: 2000
   Google Scholar
• Kahan B. D., Flechner S. M., Lorber M. I., Jensen C., Golden D., Van Buren C. T. Complications of cyclosporin therapy. World J. Surg. 1986; 10: 348
   Google Scholar
• Kennedy M. S., Yee G. C., McGuire T. R., Leonard T. M., Crowley J. J., Deeg H. J. Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients. Transplantation 1985; 40: 249
   PubMed Web of Science ®Google Scholar
• Stiller C. R., Keown P. A., Heinrichs D., Martell R., Dupre J., Jenner M., Rodger W., Wolfe B. The effect of cyclosporine on renal function in newly diagnosed diabetics. Transplant. Proc 1985; 17: 202
   Google Scholar
• Palestine A. G., Austin H. A., Nussenblatt R. B. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis. Transplant. Proc 1985; 17: 209
   Google Scholar
• Loughran T. P., Jr., Deeg H. J., Dahlberg S., Kennedy M. S., Storb R., Thomas E. D. Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis. Br. J. Haematol. 1985; 59: 547
   Google Scholar
• Thompson M. E., Shapiro A. P., Johnsen A. M., Reeves R., Itzkoff J., Ginchereau E., Hardesty R. L., Griffith B. L., Bahnson H. T., McDonald R., Jr. New onset of hypertension following cardiac transplantation: a preliminary report and analysis. Transplant. Proc 1983; 15: 2573
   Google Scholar
• Bellet M., Cabrol C., Sassano P., Leger P., Corvol P., Menard J. Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system. Am. J. Cardiol. 1985; 56: 927
   PubMed Web of Science ®Google Scholar
• Atkinson K., Biggs J., Dodds A., Concannon A. Cyclosporine-associated hepatoxicity after allogeneic marrow transplantation in man: differentiation from other causes of posttransplant liver disease. Transplant. Proc 1983; 15: 2761
   Web of Science ®Google Scholar
• Tutschka P. J., Hess A. D., Beschorner W. E., Farmer E. R., Saral R., Brookmeyer R., Santos G. W. Cyclosporine in clinical marrow transplantation: the Baltimore experience. Transplant. Proc 1983; 15: 2613
   Google Scholar
• Devineni R., McKenzie N., Keown P., Kostuk W., Stiller, Silver M. Cyclosporine in cardiac transplantation. Can. J. Surg. 1984; 27: 252
   Google Scholar
• Schade R. R., Guglielmi A., Van Thiel D. H., Thompson M. E., Warty V., Griffith B., Sanghvi A., Bahnson H., Hardesty R. Cholestasis in heart transplant recipients treated with cyclosporine. Transplant. Proc 1983; 15: 2757
   Google Scholar
• Rodger R. S. C., Turney J. H., Haines I., Michael J., Adu D., McMaster P. Cyclosporine and liver function in renal allograft recipients. Transplant. Proc 1983; 15: 2754
   Google Scholar
• Klintmalm G. B. G., Iwatsuki S., Starzl T. E. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 1981; 32: 488
   PubMed Web of Science ®Google Scholar
• Klintmalm G., Sawe J., Ringden O., von Bahr C., Magnusson A. Cyclosporine plasma levels in renal transplant patients. Transplantation 1985; 39: 132
   PubMed Web of Science ®Google Scholar
• Lorber M. I., Williams C., Van Burne C. T. Hepatobiliary complications of cyclosporine therapy in renal transplantation. Transplant. Proc 1987; 19: 1808
   PubMed Web of Science ®Google Scholar
• Gratwohl A., Muller M., Osterwalder B., Nissen C., Speck B. Nephrotoxicity of cyclosporin A in bone marrow transplant recipients. Lancet 1981; 2: 635
   Google Scholar
• Najarian J. S., Fryd D. S., Strand M., Canafax D. M., Ascher N. L., Payne W. D., Simmons R. L., Sutherland D. E. R. A single institution, randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann. Surg. 1985; 201: 142
   PubMed Web of Science ®Google Scholar
• Laupacis A. Complications of cyclosporine therapy — a comparison to azathioprine. Transplant. Proc. 1983; 15: 2748
   Google Scholar
• Beaman M., Parvin S., Veitch P. S., Walls J. Convulsions associated with cyclosporin A in renal transplant recipients. Br. Med. J. 1985; 290: 139
   PubMed Web of Science ®Google Scholar
• Atkinson K., Biggs J., Darveniza P., Boland J., Concannon A., Dodds A. Cyclosporine-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation 1984; 38: 34
   PubMed Web of Science ®Google Scholar
• Atkinson K., Biggs J., Darveniza Pl., Boland J., Concannon A., Dodds A. Cyclosporine-associated central-nervous-system toxicity after allogeneic bone-marrow transplantation. N. Engl. J. Med. 1984; 310: 527
   PubMed Web of Science ®Google Scholar
• Calne R. Y., Rolles K., Thiru S., McMaster P., Craddock G. N., White D. J. G., Evans D. B., Dunn D. C., Henderson R. G., Lewis P. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979; 2: 1033
   PubMed Web of Science ®Google Scholar
• Penn I. Cancers following cyclosporine therapy. Transplant. Proc 1987; 19: 2211
   PubMed Web of Science ®Google Scholar
• Starzl T. E., Porter K. A., Iwatsuki S., Rosenthal J. T., Shaw B. W., Jr., Atchison R. W., Nalesnik M. A., Ho M., Griffith B. P., Hakala T. R., Hardesty R. L., Jaffe R. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984; 1: 583
   PubMed Web of Science ®Google Scholar
• Dummer J. S., Hardy A., Poorsattar A., Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation 1983; 36: 259
   PubMed Web of Science ®Google Scholar
• Tolkoff-Rubin N. E., Rubin R. H. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient. Transplant. Proc 1986; 18: 168
   PubMed Web of Science ®Google Scholar
• European Transplant Group. Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Lancet 1982; 2: 57
   Google Scholar
• Bia M. J., Andiman W., Gaudio K., Kliger A., Siegel N., Smith D., Flye W. Effect of treatment with cyclosporine versus azathioprine on incidence and severity of cytomegalovirus infection posttransplantation. Transplantation 1985; 40: 610
   PubMed Web of Science ®Google Scholar
• Hardy A. M., Wajszczuk P., Suffredini A. F., Hakala T. R., Ho M. Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J. Infect. Dis. 1984; 149: 143
   PubMed Web of Science ®Google Scholar
• Van Burne D., Van Buren C. T., Flechner S. M., Maddox A. M., Verani R., Kahan B. D. De novo hemolytic; uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. Surgery 1985; 98: 54
   Google Scholar
• Bonser R. S., Adu D., Franklin I., MacMaster P. Cyclosporine induced hemolytic uremic syndrome in liver allograft recipient. Lancet 1984; 2: 1337
   Google Scholar
• Wolfe J. A., McCann R. L., Sanfilippo F. Cyclosporine associated microangiopathy in renal transplantation: a severe but potentially reversible form of early graft injury. Transplantation 1986; 41: 541
   PubMed Web of Science ®Google Scholar
• Vanrenterghem Y., Lerut T., Roels L., Gruwez J., Michielsen P., Gresele P., Colucci M., Deckmun H., Arnout J., Vermylen J. Thromboembolic complications and hemostatic changes in cyclosporine treated cadaveric kidney allograft recipients. Lancet 1985; 1: 999
   PubMed Web of Science ®Google Scholar
• Allen R. D., Michie C. A., Morris P. J., Chapman J. R. Venous thrombosis and cyclosporin. Lancet 1985; 2: 1004
   Google Scholar
• Boudreaux J. P., McHugh L., Canafax D., Ascher N., Sutherland D. E. R., Payne W., Simmons R. L., Najarian J. S., Fryd D. S. The impact of cyclosporine and combination immunosuppression in the incidence of post-transplant diabetes in renal allograft recipients. Transplantation
   Google Scholar
• Bennett W. M., Serra J., Fischer S., Norman D. J., Barry J. M. Letter to the editor. Am. J. Kidney Dis. 1985; 5: 214
   Google Scholar
• Palestine A. G., Nussenblatt R. B., Chan C.-C. Side effects of systemic cyclosporine in patients not undergoing transplantation. Am. J. Med. 1984; 77: 652
   PubMed Web of Science ®Google Scholar
• Gebhart W., Schmidt J. B., Schemper M., Spona J., Kopsa H. Cyclosporine-A induced hair growth in human renal allograft recipients and alopecia areata. Arch. Dermatol. Res. 1986; 278: 338
   Google Scholar
• Friskopp J., Klintmalm G. Gingival enlargement. A comparison between cyclosporine and azathiaprine treated renal allograft recipients. Swed. Dent. 1986; 10: 85
   Google Scholar
• Holt D. W., Marsden J. T., Johnston A., Bewick M., Tabue D. H. The relationship between cyclosporin blood concentrations and renal allograft dysfunction. Br. Med. J.
   Google Scholar
• Shaw L. M., Bowers L. D., Demers L., Freeman D., Mover T., Sanghvi A., Seltman H., Venkataramanan R. Critical issues in cyclosporine monitoring: report of the task force in cyclosporine monitoring. Clin. Chem.
   Google Scholar
• Venkataramanan R., Burckhart G. J., Ptachcinski R. J. Pharmacokinetics and monitoring of cyclosporine following orthotopic liver transplantation. Semin, Liver Dis. 1985; 5: 357
   PubMed Web of Science ®Google Scholar